Mabwell To Roll Out Denosumab Biosimilars Across Pakistan And Egypt

Xgeva Biosimilar Candidate Still Pending Approval In China

 
• By Chloe Kent

Chinese biopharma Mabwell has formed licensing agreements in Pakistan and Egypt to roll out its denosumab biosimilars.

Map of Asia and north east Africa, featuring China, Pakistan and Egypt
Mabwell has partnered with Searle in Pakistan and an unnamed business partner in Egypt • Source: Shutterstock

More from Deals

More from Business